GeminIQ Website Logo

Viewing ENDV free

Subscribe for full history, 90+ metrics, screener, watchlist...

ENDONOVO THERAPEUTICS, INC.

ENDV

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Cash
---0---0-----
Cash And Cash Equivalents At Carrying Value
000-0-0000000
Assets Current
Assets Current
0000000000000
Accounts Receivable Net Current
--0-000000000
Deposits Assets Current
------------0
Prepaid Expense And Other Assets Current
0000-00000000
Property Plant And Equipment Net
-----------00
Finite Lived Intangible Assets Net
1111122222233
Assets
1111122222333
Liabilities And Stockhold…
Accounts Payable Current
---1111111111
Interest Payable Current
---4333322222
Accounts Payable And Accrued Liabilities Current
--1----------
Liabilities Current
Liabilities Current
24232533212120182019181715
Deferred Compensation Liability Current
--54444444333
Notes Payable Current
---7777777766
Notes Payable Related Parties Classified Current
---0000000000
Derivative Liabilities Current
66917555366543
Other Liabilities Noncurrent
---0---0-----
Business Combination Contingent Consideration Liab…
000-0000---0-
Liabilities
24232633212120182019181715
Common Stock Value
0000000000000
Additional Paid In Capital
44444443424241414140403939
Stockholders Equity
Common Stock Share Subscribed But Unissued Subscri…
-------0-0-0-0-0-0-0
Stockholders Equity
-23-22-24-32-20-19-18-16-18-17-16-14-13
Preferred Stock Value
-----------00
Stockholders Equity Note Subscriptions Receivable
-0-0-0----------
Retained Earnings Accumulated Deficit
-67-66-68-75-62-61-59-56-59-57-56-53-51
Liabilities And Stockholders Equity
1111122222333
Allowance For Doubtful Accounts Receivable Current
----000000000
Debt Instrument Unamortized Discount Current
0000000000000
Common Stock Par Or Stated Value Per Share
0000000000000
Preferred Stock Par Or Stated Value Per Share
-----------0.0010.001
Preferred Stock Shares Authorized
-----------11
Common Stock Shares Authorized
2,5002,5002,5002,5002,5002,5002,5002,5002,5002,5002,5002,5002,500
Preferred Stock Shares Issued
-----------00
Common Stock Shares Issued
31927927021315915081746961522517
Shares Outstanding
31927927021315915081746961522517
Preferred Stock Shares Outstanding
-----------00

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2023-15.38%-24.18%-45.05%-6.64%-13.45%3.36%2.30%-54.48%-59.77%---
202233.54%-1.75%-12.76%0.00%0.00%0.00%58.55%75.54%111.44%-14.77%-18.27%-10.10%
20210.33%15.51%-10.23%-5.89%17.58%-23.39%-1.16%44.01%4.65%-36.84%-57.89%-47.37%
2020---------21.94%-0.97%35.00%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.00
Quick Ratio
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
Working Capital
-23.66M
-23.06M
-25.39M
-33.37M
-20.95M
-20.67M
-19.71M
-17.61M
-20.21M
-19.14M
-18.22M
-16.78M
-15.33M
Leverage & Debt
Debt to Equity
-1.04
-1.05
-1.05
-1.04
-1.07
-1.08
-1.10
-1.13
-1.12
-1.13
-1.16
-1.18
-1.21
Interest Coverage TTM
-2.15
-2.08
-2.55
-2.47
-2.55
-2.92
-2.28
-2.36
-2.00
-1.92
-1.77
-1.40
-0.78
Debt Ratio
29.15
22.88
21.33
26.12
14.51
13.01
10.94
8.86
9.53
8.47
7.33
6.51
5.67
Efficiency & Turnover
Asset Turnover TTM
0.23
0.20
0.15
0.08
0.01
0.01
0.02
0.03
0.03
0.05
0.05
0.06
0.10
Days Sales Outstanding TTM
-
-
3.36
-
103.22
171.32
37.79
4.71
17.39
16.23
14.73
26.07
7.37
Receivables Turnover TTM
-
-
108.54
-
3.54
2.13
9.66
77.52
20.98
22.49
24.78
14.00
49.56
Per Share Metrics
Diluted EPS TTM
-0.00
-0.00
-0.01
-
-0.02
-0.03
-0.04
-
-0.11
-0.12
-0.18
-
-0.25
Free Cash Flow Per Share TTM
-0.00
-0.00
-0.00
-0.00
-0.01
-0.01
-0.01
-0.02
-0.01
-0.01
-0.02
-0.03
-0.05
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
96.21%
95.14%
93.98%
92.62%
1.57%
-18.33%
67.60%
79.50%
36.92%
56.36%
52.89%
60.57%
78.37%
Operating Profit Margin TTM
-1,023.16%
-995.78%
-1,499.40%
-2,411.69%
-22,206.38%
-30,354.78%
-5,217.02%
-3,045.68%
-3,009.54%
-2,396.36%
-2,157.85%
-1,756.49%
-977.15%
Net Profit Margin TTM
-1,722.23%
-1,599.52%
-4,002.99%
-13,649.17%
-22,145.06%
-36,842.58%
-6,975.86%
-4,247.17%
-8,935.37%
-6,075.69%
-5,667.74%
-238.60%
-1,331.11%
Growth Metrics
Net Revenue Growth (1Y)
1,699.85%
2,302.27%
442.42%
85.15%
-83.14%
-90.52%
-68.91%
-55.91%
-72.16%
-63.23%
-60.94%
-46.55%
48.51%
Net Income Growth (1Y)
39.98%
4.29%
211.26%
495.02%
-58.22%
-42.54%
-61.74%
684.89%
86.90%
62.06%
-29.85%
-97.72%
-60.75%
EPS Growth (1Y)
-27.95%
-49.29%
-2.17%
155.77%
-81.97%
-74.99%
-79.87%
221.85%
-54.50%
-72.75%
-95.02%
-99.89%
-98.11%
Valuation Metrics
P/E TTM
-0.85
-0.94
-0.47
-0.14
-0.36
-0.30
-0.50
-0.30
-0.24
-0.31
-0.19
-1.25
-0.38
P/B TTM
-0.16
-0.18
-0.17
-0.08
-0.06
-0.06
-0.08
-0.06
-0.10
-0.13
-0.09
-0.03
-0.12
P/S TTM
14.70
15.11
18.84
18.51
80.00
109.55
34.77
12.77
21.79
19.08
10.90
2.97
5.12
Market Cap
3.76M
4.01M
4.16M
2.51M
1.14M
1.21M
1.41M
933.45K
1.84M
2.22M
1.43M
493.19K
1.55M
Enterprise Value
3.76M
3.97M
4.15M
9.55M
8.24M
8.45M
8.52M
7.90M
8.47M
8.75M
7.94M
6.97M
7.50M
Calculated Values
Free Cash Flow TTM
-629.90K
-688.40K
-729.04K
-678.84K
-844.59K
-890.14K
-819.59K
-986.58K
-788.14K
-715.41K
-734.32K
-741.59K
-857.12K
Net Debt
0.00
-32.60K
-10.94K
7.04M
7.10M
7.24M
7.11M
6.97M
6.63M
6.53M
6.51M
6.48M
5.95M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2020-07-01Purchase
Owner: Collier, Alan Brian
Title: CEO
Shares: 200
Price/Share: $0.10
Value: $20.00
Shares Owned: 26,219
Relationship: Officer
Ownership: Direct
2020-02-22Purchase
Owner: Collier, Alan Brian
Title: -
Shares: 100
Price/Share: $0.96
Value: $96.00
Shares Owned: 25,819
Relationship: Director
Ownership: Direct
2020-01-02Purchase
Owner: Collier, Alan Brian
Title: Ceo
Shares: 100
Price/Share: $1.75
Value: $175.00
Shares Owned: 25,418,897
Relationship: Officer
Ownership: Direct
2020-01-02Purchase
Owner: Collier, Alan Brian
Title: CEO
Shares: 100
Price/Share: $1.75
Value: $175.00
Shares Owned: 25,719
Relationship: Director,Officer
Ownership: Direct
2019-12-20Purchase
Owner: Collier, Alan Brian
Title: CEO
Shares: 100
Price/Share: $1.50
Value: $150.00
Shares Owned: 25,519
Relationship: Director,Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2023-12-31
0.00%
Inst. Shares: 60
Shares Outstanding: 298,391,943
2023-09-30
0.00%
Inst. Shares: 60
Shares Outstanding: 298,391,943
2023-06-30
0.00%
Inst. Shares: 60
Shares Outstanding: 276,330,405
2023-03-31
0.00%
Inst. Shares: 60
Shares Outstanding: 251,355,752
2022-12-31
0.00%
Inst. Shares: 60
Shares Outstanding: 139,206,511

ENDONOVO THERAPEUTICS, INC. (ENDV) — SEC Financial Statements & Analysis

ENDONOVO THERAPEUTICS, INC. (ENDV) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. ENDONOVO THERAPEUTICS, INC. trades on OTC as: ENDV. Based on its latest SEC filing (Form 10-Q, period ending 2023-09-30), ENDONOVO THERAPEUTICS, INC. reported a 1699.85% year-over-year revenue growth, a Gross Profit Margin of 96.21% (TTM), a Debt-to-Equity ratio of -1.04x, a Price-to-Sales (P/S) ratio of 14.70x (TTM), a Price-to-Book (P/B) ratio of -0.16x (TTM), at a market cap of $3.76M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
1699.85%
Gross Profit Margin TTM
96.21%
Debt To Equity
-1.04x
P/S TTM
14.70x
P/B TTM
-0.16x
Market Cap
$3.76M

Data as of 2023-09-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ENDONOVO THERAPEUTICS, INC. in?

ENDONOVO THERAPEUTICS, INC. (ENDV) operates in the Electromedical & Electrotherapeutic Apparatus industry.

What is ENDV's market cap?

ENDONOVO THERAPEUTICS, INC. (ENDV) has a market capitalization of $3.76M as of 2023-09-30.

What exchange does ENDV trade on?

ENDONOVO THERAPEUTICS, INC. (ENDV) trades on the OTC.

Where is ENDONOVO THERAPEUTICS, INC. incorporated?

ENDONOVO THERAPEUTICS, INC. is incorporated in DE.

Wall Street's data.
Main Street's price.